NCT00805753View on ClinicalTrials.gov

Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2014

Conditions
Idiopathic Membranous Nephropathy
Interventions
DRUG

ACTH

comparison of different dosages of drug

Trial Locations (2)

55905

Mayo Clinic, Rochester

M5R 0A3

University of Toronto, Toronto

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Mayo Clinic

OTHER

NCT00805753 - Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy | Biotech Hunter | Biotech Hunter